Outlook Therapeutics (OTLK) Change in Receivables (2015 - 2026)
Outlook Therapeutics (OTLK) reported Change in Receivables of $2.6 million for Q1 2026, up 289.29% quarter-over-quarter from -$1.4 million in Q4 2025.
Outlook Therapeutics (OTLK) Change in Receivables (2015 - 2026) Analysis & Trends
Outlook Therapeutics (OTLK) has 4 years of Change in Receivables data on file, last reported at $2.6 million in Q1 2026.
- Change in Receivables for Q1 2026 came in at $2.6 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $964736.0 (changed N/A YoY), and the FY2025 annual result was $1.5 million, changed N/A from the prior year.
- Change in Receivables grew to $2.6 million in Q1 2026 per OTLK's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Change in Receivables peaked at $2.6 million in Q1 2026 and troughed at -$1.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -4.08 Mn |
| 10 | Outlook Therapeutics | 51.56 Mn | 43.81 Mn | -21,888.00 | 2.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.61 Mn |
| Mar 31, 2026 | 2.61 Mn |
| Dec 31, 2025 | -1.38 Mn |
| Dec 31, 2025 | -1.38 Mn |
| Sep 30, 2025 | -260,491.00 |
| Sep 30, 2025 | -260,491.00 |
| Sep 30, 2016 | -3,670.00 |
| Sep 30, 2016 | -3,670.00 |
| Jun 30, 2016 | -501,187.00 |
| Jun 30, 2016 | -501,187.00 |
| Mar 31, 2016 | 401,767.00 |
| Mar 31, 2016 | 401,767.00 |
| Dec 31, 2015 | 83,090.00 |
| Dec 31, 2015 | 83,090.00 |
| Sep 30, 2015 | -52,910.00 |
| Sep 30, 2015 | -52,910.00 |
| Jun 30, 2015 | -1.00 Mn |
| Jun 30, 2015 | -1.00 Mn |